Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen informed lawmakers the business would consider new talks with insurers with regard to the record charges of Wegovy and copyright whenever they pledge to keep the medicines on their formularies. Sanders swiftly https://dave-s-hot-chicken-calori27261.humor-blog.com/29900493/everything-about-healthcare-news